Gene · 4595
Papers3,741
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 3,741
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The c.386A>C p.(Asn129Thr) variant in SMAD4 is likely to be pathogenic, causing Juvenile Polyposis Syndrome. A case report of a mosaic variant. | Mol Genet Genomic Med | 2024 | 38146137 | PubTator, text mining | PubMed |
| A novel AluYb8 insertion-associated non-coding RNA, lncMUTYH, impairs mitochondrial function and dampens the M2-like polarization of macrophages. | Free Radic Res | 2024 | 38145459 | PubTator, text mining | PubMed |
| Anthracycline-related cardiotoxicity in patients with breast cancer harboring mutational signature of homologous recombination deficiency (HRD). | ESMO Open | 2024 | 38118367 | PubTator, text mining | PubMed |
| Germline mutations in pediatric cancer cohort with mixed-ancestry Mexicans. | Mol Genet Genomic Med | 2024 | 38093606 | PubTator, text mining | PubMed |
| Clinicopathologic and genetic analysis of invasive breast carcinomas in women with germline CHEK2 variants. | Breast Cancer Res Treat | 2024 | 38091153 | PubTator, text mining | PubMed |
| Multiple colorectal adenomas syndrome: The role of MUTYH mutation and the polyps' number in clinical management and colorectal cancer risk. | Dig Liver Dis | 2024 | 38071180 | PubTator, text mining | PubMed |
| Breast cancers in monoallelic MUTYH germline mutation carriers have clinicopathological features overlapping with those in BRCA1 germline mutation carriers. | Breast Cancer Res Treat | 2024 | 38062336 | PubTator, text mining | PubMed |
| Identification of pathogenic germline variants in a large Chinese lung cancer cohort by clinical sequencing. | Mol Oncol | 2024 | 37885353 | PubTator, text mining | PubMed |
| Hereditary cancer testing in a diverse sample across three breast imaging centers. | Breast Cancer Res Treat | 2024 | 37861889 | PubTator, text mining | PubMed |
| The Diagnostic Yield of Genetic Testing in Patients With Multiple Colorectal Adenomas: A Specialist Center Cohort Study. | Clin Transl Gastroenterol | 2024 | 37856205 | PubTator, text mining | PubMed |
| Whole exome germline sequencing in early-onset prostate cancer patients: Genomic findings and clinical outcomes. | Prostate | 2024 | 37842866 | PubTator, text mining | PubMed |
| Colibactin mutational signatures in NTHL1 tumor syndrome and MUTYH associated polyposis patients. | Genes Chromosomes Cancer | 2024 | 37795928 | PubTator, text mining | PubMed |
| Corrigendum to 'Coinheritance of germline mutations in APC and MUTYH genes defines the clinical outcome of adenomatous polyposis syndromes' [Gene Dis (10) (2023), 1187-1189]. | Genes Dis | 2024 | 37692478 | PubTator, text mining | PubMed |
| Relation between WHO Classification and Location- and Functionality-Based Classifications of Neuroendocrine Neoplasms of the Digestive Tract. | Neuroendocrinology | 2024 | 37690447 | PubTator, text mining | PubMed |
| Increased KRAS G12C Prevalence, High Tumor Mutational Burden, and Specific Mutational Signatures Are Associated With MUTYH Mutations: A Pan-Cancer Analysis. | Oncologist | 2024 | 37589222 | PubTator, text mining | PubMed |
| [Precision Medicine for Gastric Cancer: Applicability from the Perspective of Helicobacter pylori Infection]. | Korean J Helicobacter Up Gastrointest Res | 2023 | 40502665 | PubTator, text mining | PubMed |
| Optimizing the Comet Assay-Based In Vitro DNA Repair Assay for Placental Tissue: A Pilot Study with Pre-Eclamptic Patients. | Int J Mol Sci | 2023 | 38203356 | PubTator, text mining | PubMed |
| Back-Up Base Excision DNA Repair in Human Cells Deficient in the Major AP Endonuclease, APE1. | Int J Mol Sci | 2023 | 38203235 | PubTator, text mining | PubMed |
| The Diagnostic Yield and Implications of Targeted Founder Pathogenic Variant Testing in an Israeli Cohort. | Cancers (Basel) | 2023 | 38201524 | PubTator, text mining | PubMed |
| Novel Pathogenic Variants in Hereditary Cancer Syndromes in a Highly Heterogeneous Cohort of Patients: Insights from Multigene Analysis. | Cancers (Basel) | 2023 | 38201513 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4595/papers?page=13